Changes in Ia-like antigen expression on malignant human cells.
D000230:Adenocarcinoma / Q000276:immunology; D000818:Animals; D001932:Brain Neoplasms / Q000276:immunology; D004938:Esophageal Neoplasms / Q000276:immunology; D005455:Fluorescent Antibody Technique; D000949:Histocompatibility Antigens Class II / Q000276:immunology*; D006801:Humans; D007106:Immune Sera / Q000494:pharmacology; D007945:Leukemia, Lymphoid / Q000276:immunology; D008175:Lung Neoplasms / Q000276:immunology; D008545:Melanoma / Q000276:immunology*; D051379:Mice; D010307:Parotid Neoplasms / Q000276:immunology; D011817:Rabbits; D012004:Rectal Neoplasms / Q000276:immunology; D012509:Sarcoma / Q000276:immunology; D013274:Stomach Neoplasms / Q000276:immunology; D013953:Thymus Neoplasms / Q000276:immunology; D013964:Thyroid Neoplasms / Q000276:immunology; D001749:Urinary Bladder Neoplasms / Q000276:immunology
D000949:Histocompatibility Antigens Class II; D007106:Immune Sera